Transcend Therapeutics ( Pharmaceuticals) Overview

  • Year Founded
  • 1992

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 3

Transcend Therapeutics ( Pharmaceuticals) General Information

Description

Developer of psychoactive compounds and pharmaceuticals intended for neuropsychiatry focused on patient access. The company is engaged in the development of pharmaceuticals for the treatment of diseases caused by oxidative stress and resultant tissue damage, helping patients no longer suffer from neuropsychiatric disease.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly PE-Backed
Corporate Office
  • 738 Main Street
  • Suite 431
  • Waltham, MA 02451
  • United States
+1 (617)
Primary Industry
Drug Discovery
Acquirer
KeraVision
Vertical(s)
Corporate Office
  • 738 Main Street
  • Suite 431
  • Waltham, MA 02451
  • United States
+1 (617)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Transcend Therapeutics ( Pharmaceuticals) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Transcend Therapeutics ( Pharmaceuticals)‘s full profile, request access.

Request a free trial

Transcend Therapeutics ( Pharmaceuticals) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Transcend Therapeutics ( Pharmaceuticals)‘s full profile, request access.

Request a free trial

Transcend Therapeutics ( Pharmaceuticals) FAQs

  • When was Transcend Therapeutics ( Pharmaceuticals) founded?

    Transcend Therapeutics ( Pharmaceuticals) was founded in 1992.

  • Where is Transcend Therapeutics ( Pharmaceuticals) headquartered?

    Transcend Therapeutics ( Pharmaceuticals) is headquartered in Waltham, MA.

  • What industry is Transcend Therapeutics ( Pharmaceuticals) in?

    Transcend Therapeutics ( Pharmaceuticals)’s primary industry is Drug Discovery.

  • Is Transcend Therapeutics ( Pharmaceuticals) a private or public company?

    Transcend Therapeutics ( Pharmaceuticals) is a Private company.

  • What is the current valuation of Transcend Therapeutics ( Pharmaceuticals)?

    The current valuation of Transcend Therapeutics ( Pharmaceuticals) is .

  • What is Transcend Therapeutics ( Pharmaceuticals)’s current revenue?

    The current revenue for Transcend Therapeutics ( Pharmaceuticals) is .

  • How much funding has Transcend Therapeutics ( Pharmaceuticals) raised over time?

    Transcend Therapeutics ( Pharmaceuticals) has raised $18M.

  • Who are Transcend Therapeutics ( Pharmaceuticals)’s investors?

    Advent International has invested in Transcend Therapeutics ( Pharmaceuticals).

  • When was Transcend Therapeutics ( Pharmaceuticals) acquired?

    Transcend Therapeutics ( Pharmaceuticals) was acquired on 28-May-1999.

  • Who acquired Transcend Therapeutics ( Pharmaceuticals)?

    Transcend Therapeutics ( Pharmaceuticals) was acquired by KeraVision.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process